4//SEC Filing
Brister Mark 4
Accession 0001214659-19-000154
CIK 0001427570other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 6:32 PM ET
Size
5.5 KB
Accession
0001214659-19-000154
Insider Transaction Report
Form 4
Brister Mark
VP of Research and Development
Transactions
- Award
Stock Option (Right to Buy)
2019-01-02+100,000→ 100,000 totalExercise: $2.30Exp: 2029-01-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The Option shall vest as to 1/48th of the Shares underlying the Option on each monthly anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date.
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001323223
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 6:32 PM ET
- Size
- 5.5 KB